ID

32937

Description

An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01022112

Link

https://clinicaltrials.gov/show/NCT01022112

Keywords

Versions (1)
  1. 11/21/18 11/21/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 21, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes Mellitus NCT01022112

English

Eligibility Type 2 Diabetes Mellitus NCT01022112

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged from 20 to 80 years inclusive on the day of informed consent;
Description

Age | Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021430
patients who was diagnosed with type 2 diabetes mellitus at least 3 months before the start of the run-in period;
Description

Non-Insulin-Dependent Diabetes Mellitus Disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
patients with hba1c of ≥6.5% and ≤9.5% (according to the japan diabetic society [jds] criteria) on the start day of the run-in period;
Description

Hemoglobin A1c measurement

Data type

boolean

Alias
UMLS CUI [1]
C0474680
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
type i diabetes mellitus, diabetes mellitus resulting from pancreatic disorder, or secondary diabetes mellitus (acromegaly, cushing's syndrome, etc.);
Description

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus Due to Pancreatic Disease | Secondary diabetes mellitus | Acromegaly | Cushing Syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2,1]
C0011849
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0030286
UMLS CUI [3]
C0271640
UMLS CUI [4]
C0001206
UMLS CUI [5]
C0010481
past or current history of severe diabetic complications (proliferative diabetic retinopathy, stage iii or later stage overt nephropathy, diabetic ketoacidosis, or serious diabetic neuropathy);
Description

Complications of Diabetes Mellitus Severe | Proliferative diabetic retinopathy | Kidney Disease TNM clinical staging | Diabetic Ketoacidosis | Diabetic Neuropathy Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0342257
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0154830
UMLS CUI [3,1]
C0022658
UMLS CUI [3,2]
C3258246
UMLS CUI [4]
C0011880
UMLS CUI [5,1]
C0011882
UMLS CUI [5,2]
C0205404
fasting blood glucose of >270 mg/dl on the start day of the run-in period or at week 2 of the run-in period;
Description

Fasting blood glucose measurement

Data type

boolean

Alias
UMLS CUI [1]
C0428568
egfr of <60 ml/min/1.73 m2 on the start day of the run-in period;
Description

Estimated Glomerular Filtration Rate

Data type

boolean

Alias
UMLS CUI [1]
C3811844
systolic blood pressure of ≥160 mmhg or diastolic blood pressure of ≥100 mmhg on the start or end day of the run-in period;
Description

Systolic Pressure | Diastolic blood pressure

Data type

boolean

Alias
UMLS CUI [1]
C0871470
UMLS CUI [2]
C0428883
history of myocardial infarction, unstable angina, or cerebrovascular disorder within 3 months before the start of the run-in period;
Description

Myocardial Infarction | Angina, Unstable | Cerebrovascular Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0007820
concurrent serious (e.g., requiring inpatient hospitalization or surgical intervention) renal or hepatic disease;
Description

Kidney Disease Serious | Liver disease Serious | Hospitalization Required | Surgical intervention Required

Data type

boolean

Alias
UMLS CUI [1,1]
C0022658
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C0023895
UMLS CUI [2,2]
C0205404
UMLS CUI [3]
C1708385
UMLS CUI [4,1]
C0549433
UMLS CUI [4,2]
C1514873
past or current history of malignant tumor; however, this criterion shall not apply to those who have been free of relapse for at least 5 years even with a history of malignant tumor.
Description

Malignant Neoplasms | Exception Relapse Free of

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0035020
UMLS CUI [2,3]
C0332296
past or current history of drug hypersensitivity such as shock and anaphylactoid symptoms;
Description

Drug Allergy | Shock | Symptoms Anaphylactoid

Data type

boolean

Alias
UMLS CUI [1]
C0013182
UMLS CUI [2]
C0036974
UMLS CUI [3,1]
C1457887
UMLS CUI [3,2]
C1706805
pregnant women, lactating mothers, or women of childbearing potential;
Description

Pregnancy | Breast Feeding | Childbearing Potential

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C3831118
any condition that subjects are assessed to be ineligible by the investigator (sub investigator).
Description

Condition Study Subject Participation Status Ineligible

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C1512714
Back to the top of the page

Similar models

Eligibility Type 2 Diabetes Mellitus NCT01022112

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Informed Consent
Item
aged from 20 to 80 years inclusive on the day of informed consent;
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
patients who was diagnosed with type 2 diabetes mellitus at least 3 months before the start of the run-in period;
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Hemoglobin A1c measurement
Item
patients with hba1c of ≥6.5% and ≤9.5% (according to the japan diabetic society [jds] criteria) on the start day of the run-in period;
boolean
C0474680 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus Due to Pancreatic Disease | Secondary diabetes mellitus | Acromegaly | Cushing Syndrome
Item
type i diabetes mellitus, diabetes mellitus resulting from pancreatic disorder, or secondary diabetes mellitus (acromegaly, cushing's syndrome, etc.);
boolean
C0011854 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0030286 (UMLS CUI [2,3])
C0271640 (UMLS CUI [3])
C0001206 (UMLS CUI [4])
C0010481 (UMLS CUI [5])
Complications of Diabetes Mellitus Severe | Proliferative diabetic retinopathy | Kidney Disease TNM clinical staging | Diabetic Ketoacidosis | Diabetic Neuropathy Serious
Item
past or current history of severe diabetic complications (proliferative diabetic retinopathy, stage iii or later stage overt nephropathy, diabetic ketoacidosis, or serious diabetic neuropathy);
boolean
C0342257 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0154830 (UMLS CUI [2])
C0022658 (UMLS CUI [3,1])
C3258246 (UMLS CUI [3,2])
C0011880 (UMLS CUI [4])
C0011882 (UMLS CUI [5,1])
C0205404 (UMLS CUI [5,2])
Fasting blood glucose measurement
Item
fasting blood glucose of >270 mg/dl on the start day of the run-in period or at week 2 of the run-in period;
boolean
C0428568 (UMLS CUI [1])
Estimated Glomerular Filtration Rate
Item
egfr of <60 ml/min/1.73 m2 on the start day of the run-in period;
boolean
C3811844 (UMLS CUI [1])
Systolic Pressure | Diastolic blood pressure
Item
systolic blood pressure of ≥160 mmhg or diastolic blood pressure of ≥100 mmhg on the start or end day of the run-in period;
boolean
C0871470 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
Myocardial Infarction | Angina, Unstable | Cerebrovascular Disorders
Item
history of myocardial infarction, unstable angina, or cerebrovascular disorder within 3 months before the start of the run-in period;
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0007820 (UMLS CUI [3])
Kidney Disease Serious | Liver disease Serious | Hospitalization Required | Surgical intervention Required
Item
concurrent serious (e.g., requiring inpatient hospitalization or surgical intervention) renal or hepatic disease;
boolean
C0022658 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C1708385 (UMLS CUI [3])
C0549433 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
Malignant Neoplasms | Exception Relapse Free of
Item
past or current history of malignant tumor; however, this criterion shall not apply to those who have been free of relapse for at least 5 years even with a history of malignant tumor.
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0035020 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
Drug Allergy | Shock | Symptoms Anaphylactoid
Item
past or current history of drug hypersensitivity such as shock and anaphylactoid symptoms;
boolean
C0013182 (UMLS CUI [1])
C0036974 (UMLS CUI [2])
C1457887 (UMLS CUI [3,1])
C1706805 (UMLS CUI [3,2])
Pregnancy | Breast Feeding | Childbearing Potential
Item
pregnant women, lactating mothers, or women of childbearing potential;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3])
Condition Study Subject Participation Status Ineligible
Item
any condition that subjects are assessed to be ineligible by the investigator (sub investigator).
boolean
C0348080 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1512714 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial